The Size of the Polymerase Chain Reaction Market in Latin America is valued at USD 1.07 billion in 2022 and estimated to be growing at a CAGR of 6.70%, to reach USD 1.48 billion by 2027 during the forecast period 2022 to 2027.
Polymerase chain response (PCR) is a method used as a part of molecular biology to increase a single or a few copies of a portion of DNA over several orders of magnitude, producing thousands to a large number of duplicates of a specific DNA sequence.
PCR strategies have prepared for development in life sciences research and sub-atomic diagnostics through its most potent elements, for example, absolute identification and Quantification of DNA and RNA. Analysts can analyze and quantify uncommon alleles and point mutations utilizing advanced PCR frameworks, for example, computerized PCR.
The developing geriatric populace, combined with an increasing predominance of chronic diseases, and technological progressions in the field of life science are the key variables driving the development of qPCR and dPCR market. The rising rate of infectious diseases and genetic disorders and expanded public-private speculations, finances, and grants for PCR-based research are further helping the market development. The high cost of dPCR instruments and technological limitations related to qPCR and dPCR are the key components restricting the development of this market.
This research report on the Latin America Polymerase Chain Reaction Market has been segmented and sub-segmented into the following categories
By Types:
By Type Of Application:
By Country:
Noteworthy Companies dominating the Latin America Polymerase Chain Reaction Market Profiled in the Report are Beckman Coulter, Becton, Dickinson and Company, Cepheid, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, GE, Harvard Bioscience, Maxim Biotech, Promega, Kapa Biosystems, RainDance Technologies, and Siemens Healthcare.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 PCR consumables
5.1.3 PCR instruments
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 DNA fingerprinting
5.2.3 DNA sequencing
5.2.4 DNA cloning
5.2.5 Gene expression
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.2 Brazil
6.3 Mexico
6.4 Argentina
6.5 Rest of Latin America
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Roche Diagnostics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Thermo Fisher Scientific
8.3 Agilent Technologies
8.4 Abbott Laboratories
8.5 Sigma-Aldrich Corporation Beckman Coulter
8.6 Becton Dickinson
8.7 Bio-Radand QIAGEN
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.